摘要
目的探讨红细胞分布宽度(RDW)、血清降钙素原(PCT)在重症肺炎中的应用价值。方法选取从2016年1~10月入院治疗的肺部感染患者62例,其中重症肺炎患者32例(A组)和普通肺炎患者30例(B组);对其进行WBC、RDW和PCT测定。结果治疗前后两组的WBC比较差异无统计学意义(P>0.05),重症肺炎组的RDW、PCT比普通肺炎组高,差异均有统计学意义(P<0.05);经过72h的治疗后,两组患者的RDW、PCT值均较前下降(P<0.05)。结论 RDW和PCT联合检测对重症肺炎的鉴别诊断、治疗及预后评估均有重要的指导作用。
Objective To explore the erythrocyte hemoglobin distribution width(RDW) and procalcitonin(PCT)+ in severe pneumonia. Methods 62 cases of patients with pulmonary infection cured in our hospital from January 2016 to October 2016 were selected. Among them, 32 cases of patients with severe pneumonia were divided into group A, and 30 cases of patients with general pneumonia were divided into group B. WBC, RDW and PCT were detected. Results There was no significant difference in WBC between the two groups before and after treatment(P 〉 0.05). The RDW and PCT in severe pneumonia group were higher than those in general pneumonia group, and the difference was statistically significant(P 〈 0.05). After 72 hours of treatment, the RDW and PCT values of the patients in the two groups were lower than before(P 〈 0.05). Conclusion Combined detection of RDW and PCT plays an important role in the differential diagnosis, treatment and prognosis of severe pneumonia.
出处
《中国医药科学》
2017年第2期172-174,共3页
China Medicine And Pharmacy
关键词
重症肺炎
红细胞分布宽度
降钙素原
价值
Severe pneumonia
Erythrocyte hemoglobin distribution width
Procalcitonin
Value